Initial Guidance on Use of Monoclonal Antibody Therapy for Treatment of Coronavirus Disease 2019 in Children and Adolescents

Clicks: 136
ID: 272783
2021
Article Quality & Performance Metrics
Overall Quality Improving Quality
0.0 /100
Combines engagement data with AI-assessed academic quality
AI Quality Assessment
Not analyzed
Abstract
Although monoclonal antibody therapies for coronavirus disease 2019 have received emergency use authorization for treatment of adolescents in specified high-ris
Reference Key
joshua2021journalinitial Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Wolf, Joshua;Abzug, Mark J;Wattier, Rachel L;Sue, Paul K;Vora, Surabhi B;Zachariah, Philip;Dulek, Daniel E;Waghmare, Alpana;Olivero, Rosemary;Downes, Kevin J;James, Scott H;Pinninti, Swetha G;Yarbrough, April;Aldrich, Margaret L;MacBrayne, Christine E;Soma, Vijaya L;Grapentine, Steven P;Oliveira, Carlos R;Hayes, Molly;Kimberlin, David W;Jones, Sarah B;Bio, Laura L;Morton, Theodore H;Hankins, Jane S;Maron, Gabriela M;Timberlake, Kathryn;Young, Jennifer L;Orscheln, Rachel C;Schwenk, Hayden T;Goldman, David L;Groves, Helen E;Huskins, W Charles;Rajapakse, Nipunie S;Lamb, Gabriella S;Tribble, Alison C;Lloyd, Elizabeth C;Hersh, Adam L;Thorell, Emily A;Ratner, Adam J;Chiotos, Kathleen;Nakamura, Mari M;
Journal journal of the pediatric infectious diseases society
Year 2021
DOI
DOI not found
URL
Keywords

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.